Nguyen, Doan C. http://orcid.org/0000-0002-5389-6731
Saney, Celia
Hentenaar, Ian T.
Cabrera-Mora, Monica
Capric, Violeta
Woodruff, Matthew C. http://orcid.org/0000-0002-5252-7539
Andrews, Joel
Lonial, Sagar
Sanz, Ignacio http://orcid.org/0000-0003-4182-587X
Lee, F. Eun-Hyung http://orcid.org/0000-0002-6133-5942
Funding for this research was provided by:
NIH/NIAID (1R01AI121252, 1P01AI125180, U01AI141993, U54CA260563, U19AI110483, T32AI070081)
The Bill & Melinda Gates Foundation (INV-002351)
Article History
Received: 24 August 2023
Accepted: 7 February 2024
First Online: 13 February 2024
Competing interests
: F.E.L. is the founder of Micro-Bplex, Inc., serves on the scientific board of Be Biopharma, is a recipient of grants from the BMGF and Genentech, Inc., and has served as a consultant for Astra Zeneca. I.S. has consulted for GSK, Pfizer, Kayverna, Johnson & Johnson, Celgene, Bristol Myer Squibb, and Visterra. F.E.L., D.N., and I.S. are inventors of the patents (assigned to Emory University) concerning the plasma cell survival media related to this work. The other authors declare no conflicts of interest.